Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C, 14
MDDGC14

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 11 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Elevated creatine kinase (CK) levels circulatory 100 % 26133662 2024-04-30
Neck weakness nervous 100 % 26133662 2024-04-30
Myopathy skeletal 73 % 26133662 2024-04-30
Motor delay nervous 73 % 26133662 2024-04-30
Dystrophic muscles skeletal 55 % 26133662 2024-04-30
Muscle weakness skeletal 55 % 26133662 2024-04-30
Mental retardation nervous 18 % 26133662 2024-04-30
Ptosis nervous 18 % 26133662 2024-04-30
Developmental delay nervous 18 % 26133662 2024-04-30
Recurrent infections lymphatic 9 % 26133662 2024-04-30
Seizures nervous 9 % 26133662 2024-04-30
Bulbar dysfunction nervous 9 % 26133662 2024-04-30



List of references:


Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
Katsiaryna Belaya, Pedro M Rodríguez Cruz, Wei Wei Liu, Susan Maxwell, Simon McGowan, Maria E Farrugia, Richard Petty, Timothy J Walls, Maryam Sedghi, Keivan Basiri, Wyatt W Yue, Anna Sarkozy, Marta Bertoli, Matthew Pitt, Robin Kennett, Andrew Schaefer, Kate Bushby, Matt Parton, Hanns Lochmüller, Jacqueline Palace, Francesco Muntoni, David Beeson,



Brain : a journal of neurology - Sep 2015